NCT04390113: A reported trial by AlloVir
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04390113 |
|---|---|
| Title | Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant (HCT) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 18, 2021 |
| Completion date | Jan. 30, 2024 |
| Required reporting date | Jan. 29, 2025, midnight |
| Actual reporting date | April 18, 2024 |
| Date last checked at ClinicalTrials.gov | Oct. 31, 2025 |
| Days late | None |